Clinical trial
A Phase II, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of CVN424 in Parkinson's Disease Patients With Motor Fluctuations
NCT04191577 is registered in ClinicalTrials.gov with Cerevance Beta, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase II, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of CVN424 in Parkinson's Disease Patients With Motor Fluctuations
- Lead sponsor
- Cerevance Beta, Inc.
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- December 2, 2019
- Completion date
- December 13, 2021
- Enrollment
- 136 (actual)
- Sites
- 21
Conditions
As the registry lists them; a condition with its own page is linked.